Company Overview and News

 
Dick Smith bosses sued over company collapse

2017-03-21 perthnow.com.au
THE former chief executive and chief financial officers of Dick Smith are among eight ex-company leaders being sued following the collapse of the electronics chain.
Upvote Downvote

 
Recievers launch legal action against Dick Smith directors, executives

2017-03-20 theage.com.au
The receivers of collapsed electronics chain Dick Smith have launched legal action against eight directors and executives, including ex-CEO Nick Abboud for alleged breaches of their duty to exercise reasonable care.
Upvote Downvote

 
Recievers launch legal action against Dick Smith directors, executives

2017-03-20 smh.com.au
The receivers of collapsed electronics chain Dick Smith have launched legal action against eight directors and executives, including ex-CEO Nick Abboud for alleged breaches of their duty to exercise reasonable care.
Upvote Downvote

 
Ingham's shares hatch to wary IPO market

2016-11-07 theage.com.au
The debut of the $1.2 billion Inghams Group float on the ASX on Monday is the latest test for the Australian initial public offerings market, which has been dealt a blow by the repricing of three floats, including that of the chicken processor.
Upvote Downvote

 
Ingham's shares hatch to wary IPO market

2016-11-07 smh.com.au
The debut of the $1.2 billion Inghams Group float on the ASX on Monday is the latest test for the Australian initial public offerings market, which has been dealt a blow by the repricing of three floats, including that of the chicken processor.
Upvote Downvote

 
Markets Live: ASX up as miners dig deep

2016-07-15 theage.com.au
After a strong early start on jumping iron ore and oil prices, the ASX drooped but then came home strong to record a fifth session of gains, with the top 200 index within sight of the 5400-point mark.
Upvote Downvote

 
Dick Smith Group's autopsy – bad strategy, not foul play

2016-07-15 theage.com.au
The first official autopsy report into the demise of the Dick Smith electronics group  appears to find the cause of death was management ineptitude rather than foul play.
Upvote Downvote

 
Dick Smith Group's autopsy – bad strategy, not foul play

2016-07-13 smh.com.au
Citi's Craig Woolford and Platypus' Donald Williams see plenty of upside with JB Hi-Fi, and not just because of its competitor's collapse.
Upvote Downvote

 
Kogan.com IPO 'different to the others', says founder

2016-06-09 smh.com.au
Online retail entrepreneur Ruslan Kogan has distanced Kogan.com from recent e-commerce sharemarket flops, saying the business has been earnings positive "from day one" despite being capital constrained.
Upvote Downvote

 
Tegel IPO at $1.55 a share, near bottom of the range

2016-04-19 nzherald.co.nz
Tegel Group Holdings, the poultry group controlled by private equity firm Affinity Equity Partners, will sell shares at $1.55 apiece in the year's first initial public offering, near the bottom of its indicative price range.
Upvote Downvote

 
Tegel IPO to raise up to $344 million, listing on May 3

2016-03-31 nzherald.co.nz
Shares in chicken producer Tegel have been priced in an indicative range of $1.55 to $2.50, giving the company an implied market value of up to $636 million, according to the product disclosure statement.
Upvote Downvote

 
ATO's private company list kicks up more questions about artistry of tax arrangements

2016-03-22 smh.com.au
The first thing to note about today's data dump from the Australian Taxation Office is the agility and innovation of Australia's wealthiest private companies when it comes to paying tax. Or not.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

12h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...